Trial intelligence / Profile preview

The Effect of Spironolactone on Pain in Older People with Osteoarthritis

2013-002638-19Phase 4Completed

Sponsor
University of Dundee
Start
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Spironolactone plus usual analgesia with Placebo plus usual analgesia (2 arms). Primary endpoint: Change in WOMAC pain subscale at 12 weeks. Started Sep 2013; status: completed.

02

Drugs

spironolactone
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2013-002638-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-002638-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call